PTAB challenges

Proceedings overview

One AIA trial proceeding has been filed against US patent 11826217. This proceeding, IPR2025-01065, resulted in a discretionary denial of institution, meaning the claims were not evaluated on the merits and remain sustained. This outcome strengthens the patent owner's position as the patent has survived an IPR challenge.

IPR2025-01065 — Ascentcare Dental Products, Inc. v. Solmetex LLC

• Type: Inter Partes Review
• Filed: 2025-06-06
• Status: Discretionary Denial (Procedural) – the petition for inter partes review was denied institution on procedural grounds, rather than on the merits of patentability.
• Judge panel: Not publicly available from the search results, as institution was denied.
• Petition grounds: Not publicly available from the search results, as institution was denied on procedural grounds.
• Institution decision: Denied (date not specified in available data). The PTAB issued a "Discretionary Denial," meaning the Board declined to institute the IPR. This procedural denial indicates that the merits of the patentability challenge were not fully assessed.
• Final Written Decision: Not issued, as institution was denied.
• Settlement / termination: Not applicable, as institution was denied.
• Appeal: No Federal Circuit appeal has been identified in the available data.
• Defensive value: This proceeding indicates that the patent survived an initial challenge at the PTAB, making future IPR-based defenses against the same claims potentially more difficult for parties with similar grounds or arguments. The claims remain untested on the merits in an IPR.

Strategic summary

All claims of US11826217 remain SUSTAINED and UNTESTED on the merits at the PTAB. The single IPR filed, IPR2025-01065, was denied institution on procedural grounds (discretionary denial), meaning the Board did not reach a decision on the patentability of the challenged claims. Consequently, no claims were canceled, and the patent's scope has not been narrowed through PTAB review.

The estoppel landscape remains open for most prior-art grounds. While Ascentcare Dental Products, Inc. (and their privies) would be estopped under § 315(e)(2) from raising any ground they raised or reasonably could have raised in IPR2025-01065, the specific grounds of the petition are not public due to the discretionary denial. For other defendants facing assertion of this patent, prior-art grounds are generally still available, as the patent has not undergone a full merits review at the PTAB. The patent owner, Solmetex LLC, successfully defended against this IPR, suggesting a willingness to enforce its patent rights.

There are no apparent pattern signals of multiple IPRs from the same petitioner or aggressive PTAB appeals by the patent owner. The petitioner, Ascentcare Dental Products, Inc., is a known entity in the dental products space, sometimes involved in patent litigation. The fact that the IPR was denied on procedural grounds could indicate a strategic decision by the PTAB (e.g., related to parallel litigation or other factors), rather than a definitive statement on the strength of the patent's claims against the asserted prior art.

Recommended next steps

• Since IPR2025-01065 resulted in a discretionary denial, there is no FWD to link to for claim invalidation. The patent remains active and its claims have not been formally challenged on the merits at the PTAB.
• No active proceedings are pending.
• The absence of further PTAB activity on this patent, especially given its recent grant date (2023-11-28), might suggest it has not yet been widely asserted, or that potential challengers are assessing their options. For a defendant, this means that the patent's validity has not been robustly tested in post-grant proceedings.

---

Citations:
PTAB case IPR2025-01065 filed (Not Instituted - Procedural). https://portal.unifiedpatents.com/ptab/case/IPR2025-01065